Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Children's Oncology Group
St. Jude Children's Research Hospital
Children's Oncology Group
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Children's Oncology Group
New Approaches to Neuroblastoma Therapy Consortium
Ann & Robert H Lurie Children's Hospital of Chicago
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital